key: cord-0008892-mvpcn4h1
authors: Fenner, Frank
title: The pathogenesis and frequency of viral infections of man
date: 2002-11-14
journal: Pharmacol Ther
DOI: 10.1016/0163-7258(79)90015-9
sha: f030c1f2271f6441facccaa127d912a60c9a0794
doc_id: 8892
cord_uid: mvpcn4h1

nan

The pathogenesis of viral infections involves three types of interaction between viruses and their vertebrate hosts: the way in which viruses spread (or fail to spread) through the body, the immune response and its influence on viral infections, and the many non-immunological factors which affect virus-host interactions.

It is relevant here to consider the terms pathogenicity and virulence as they apply to viruses. Neither can be used without reference to the host, for they apply to the interaction between host and parasite. A virus is pathogenic for a particular host if it can infect that host and produce signs and symptoms of disease in it. But infection is not synonymous with disease; many infections, even with virulent viruses, may be subclinical or inapparent (see Table 9 ). A given strain of virus is said to be more virulent than another if it regularly produces more severe disease in a host in which both strains are pathogenic. Live vaccines are usually attenuated strains, i.e. they are less virulent than the wild-type virus. It is best not to use the word 'virulent' to describe the killing of cultured cells by viruses; the appropriate term is 'cytocidal'. Cytocidal viruses are not invariably highly virulent in intact animals; conversely, noncytocidal viruses like rubella or the leukemia viruses may cause severe disease.

Since viruses must get into susceptible cells before they can produce disease, it is necessary to consider first the important portals of entry and exit of viruses from the body (Table 1) . Some viruses have a single mode of transmission, others, as the last term of the cryptograms shown in Table 2 of the previous article indicate, have several. The important portals of entry are the three major and two minor epithelial surfaces: the skin, the respiratory tract, and the alimentary tract; and the conjunctiva and genital tract (Fig. I) . Localized pathological changes may be produced when viruses breach these barriers, although invasion may also occur without the development of a local lesion. After the surface has been breached the infection may remain localized, or it may spread through the organism via the lymphatics, blood vessels, or nerves. Mims, 1976) .

Man samples the environmental air about 20 times a minute during breathing, so that the respiratory tract is a very important portal of entry for viruses. Some viruses cause silent initial infection of the respiratory tract prior to systemic distribution; most remain localized in the upper or lower respiratory tract and produce disease as a result of their multiplication there. These are called the 'respiratory viruses' (Table 2) , and include the rhinoviruses, orthomyxoviruses, paramyxoviruses, and coronaviruses, as well as several adenoviruses and enteroviruses. Although infection is usually by inhalation of aerosols produced by coughing, sneezing or singing, high concentrations of respiratory viruses are often found on the hands and frequent inadvertent contact of fingers with the nose and eyes may help to spread such agents. INFLUENZA As an example of the way in which these viruses produce respiratory disease, we describe the pathogenesis of influenza, the most important respiratory viral infection of man.

Infectious particles may be implanted directly on nasal surfaces from contaminated hands or from large droplets, or may reach the lower respiratory passages from aerosols. In general, aerosol particles of 3/~m in size reach the alveolus and those of 6/~m or greater are retained in the upper respiratory tract. Symptoms are produced by multiplication in the cells of the upper and lower respiratory tract; generalization via the bloodstream is a very rare event.

Virus particles alighting on the mucus film that covers the epithelium of the upper respiratory tract may undergo one of several fates. If the individual has previously recovered from an infection with that strain of influenza virus, antibody (mainly IgA) in the mucous secretion may combine with the virus and neutralize it. Mucus also contains glycoprotein inhibitors which combine with virus and prevent it from attaching to the specific receptors on the host cell; eventually these inhibitors are destroyed by the viral neuraminidase.

The successful infection of a few cells by influenza virus, and the passage of newly synthesized virions .from these cells into the respiratory mucus and then into other cells may lead to progressive infection, which is aided by the transudation of fluid that follows cellular injury and helps to disperse the virus. On the other hand, the inflammation also results in an increased diffusion of plasma constituents, including antibody and nonspecific inhibitors, which may inactivate the virus and cut short the infection. Interferon may also play a role in limiting the spread of infection.

Although the release of virus does not cause obvious cell damage, the end result of infection is necrosis and desquamation of the respiratory epithelium. Usually damage is confined to the epithelial cells of the upper respiratory tract, but in cases of pneumonia there are foci of infection in the epithelial cells of the bronchi, bronchioles and alveoli, and in alveolar macrophages, but not in the vascular endothelium. Destruction of the respiratory epithelium by influenza virus lowers its resistance to secondary bacterial invaders, especially pneumococci and staphylococci.

Upper respiratory tract infection (U.R.T.I.) is the most common disease of man, and most of it is caused by viruses. It has been estimated to account for an average of six episodes per person per annum, up to one third of all calls on general practitioners, and countless millions of lost working hours. Attempts have been made to assess the relative contributions of the various respiratory viruses to the total spectrum of respiratory disease (Fig. 3) . The rhinoviruses, coronaviruses, parainfluenza, and respiratory syncytial viruses are the most common agents, usually producing trivial disease of the upper respiratory tract, especially when they infect adults. On the other hand, most of the respiratory infections in young children that are severe enough to require hospitalization are attributable to respiratory syncytial, parainfluenza, and influenza viruses. In respiratory syncytial virus infections of infants, if humoral antibody is present in the absence of local antibody, a more severe reaction may occur, possibly through antigen/antibody deposition on the membrane of alveolar cells.

Most of the respiratory viruses are highly infectious, spreading as droplets generated during coughing, sneezing, talking, etc. Respiratory viral infections have short incubation periods, of the order of 2-5 days. Hence they regularly produce epidemics, especially in the winter and spring. A striking example is the respiratory syncytial virus, which precipitates an abrupt epidemic in infants every winter. More widespread epidemics, which may close schools and factories, are produced every 2-3 yr by influenza A and, somewhat less frequently, by influenza B. Adenovirus types 3, 4, 7, 14, 21 and parainfluenza type 1 occasionally cause limited outbreaks in military camps and other semiclosed communities of young people. The other important respiratory viruses, namely the rhinoviruses, coronaviruses, parainfluenza viruses, adenoviruses 1, 2, 5, and 6, and coxsackieviruses A21, A24, B3, and BS, tend rather to be endemic in the community, causing only sporadic cases or occasional small outbreaks. Respiratory syncytial and parainfluenza viruses are so prevalent that the first infections with them usually occur in infancy or early childhood. In contrast, some of the enteroviruses and adenoviruses may not be encountered until adult life. Subclinical infections do not occur nearly as commonly with respiratory viruses as with viruses entering the body by other routes. Acquired immunity to the respiratory viruses tends to be relatively short-lived.. Interferon confers limited protection against all viruses for a few weeks, and specific immunity against the homologous serotype, mediated principally by IgA, persists for perhaps a few years, then wanes. Hence reinfection with the same agent sometimes occurs. Even more significant, however, is the fact that a given syndrome may be caused by a large number of serologically distinguishable agents, showing little or no cross-immunity. Many of the viruses listed in Table 2 can, on occasion, produce disease at any level in the respiratory tract--coryza, pharyngitis, laryngitis, croup, bronchitis, bronchiolitis, or pneumonia (Fig. 4) . For example, respiratory syncytial virus or parainfluenza virus type 3 can cause a potentially lethal pneumonitis, bronchiolitis, or croup in infants, but usually little more than a sore throat or common cold-like illness in adults. Indeed, the syndromes merge into one another as the infection moves progressively down the respiratory tract. In general, the disease becomes more serious the lower the virus goes.

In addition, the respiratory tract is the portal of entry for several viruses that cause generalized diseases: smallpox, measles, chickenpox, rubella, cytomegalovirus infection, mononucleosis, and sometimes various enterovirus infections. Usually no local lesion or symptoms occur during the primary infection, although there may be an exudative pharyngitis in infectious mononucleosis.

Only non-enveloped viruses regularly cause infection of the human alimentary tract, because the infectivity of enveloped viruses is destroyed by the bile. Furthermore, the rhinoviruses are too acid-labile to pass the stomach. The main viruses that infect the gut are therefore the enteroviruses, reoviruses, adenoviruses, and hepatitis viruses. Many of the same barriers that prevent cell attachment and penetration may exist there as in the respiratory tract, including local IgA antibody. Local humoral and cell-mediated immunity follows natural viral infections of the intestinal tract and forms the basis for immunity following oral administration of live vaccines, such as Sabin poliovaccines.

Most enteroviruses are parasites of the intestinal tract, but proof of the etiological role of coxsackieviruses and echoviruses in gastroenteritis has been difficult to obtain. Most infections are symptomless. Less frequently, enteroviruses (e.g. poliovirus) may spread from the alimentary tract to cause generalized infection. Important though these infections are, we know very little of their pathogenesis before they leave the gut. Adenoviruses are primarily pathogens of the respiratory tract but many serotypes can multiply asymptomatically in the alimentary tract and are excreted in the feces. The two kinds of hepatitis virus can cause infection via the alimentary tract; hepatitis A usually, hepatitis B rarely. In neither case does the initial infection of the gut cells produce symptoms.

However there are some viruses that cause gastroenteritis, which is second only to respiratory infection as a cause of human morbidity, and in many parts of the world is a major killer of undernourished children. Symptoms include diarrhea, with a variable degree of nausea, vomiting, malaise, cramping abdominal pain, and fever. The incubation period is 24-96 hr (average 2 days), the duration of illness 12-48 hr, and complete recovery is the usual outcome. The etiology of most cases remained obscure ( immunoelectron microscopy on ultracentrffuged fecal preparations. The Norwalk agent is a 27 nm icosahedral virus morphologically resembling a parvovirus, and seems to be a major cause of the disease variously known as 'epidemic diarrhea and vomiting', or 'winter vomiting disease'. This agent occurs predominantly in outbreaks of acute infectious nonbacterial gastroenteritis during the colder months (September to March) in both adults and children throughout the world. It shows no serological cross-reaction with the Hawaii agent, which may be a member of the same family.

The~rotavirus is a member of the Reoviridae family. It appears to be the major cause of 'infantile enteritis' in young children throughout the world, infecting most infants in the first or second year of life with a low but significant mortality, but is relatively uncommon in adults.

Additional viruses will doubtless be implicated in gastroenteritis. Coronaviruses and adenoviruses, which currently defy in vitro cultivation, are commonly visualized by electron microscopy in feces from patients with gastroenteritis. The role of echoviruses and coxsackieviruses is still unclear. Certain serotypes, e.g. echoviruses 11, 14, 18, and 22, have been repeatedly recovered during epidemics, but the evidence for their causal relationship to the disease must still be regarded as circumstantial in light of the frequency with which echoviruses are excreted by well people (Table 3 ).

When viruses are introduced into the skin by injection, arthropod bite, or through a breach caused by mechanical trauma, lesions may be produced at the site. The only localized viral infections of the skin in man are human warts, which are a trivial and very common hyperplasia due to a virus of papilloma subgroup of the papovaviruses, the recurrent vesicular eruptions of herpes simplex on skin and mucous membranes, and the proliferative inflammatory lesions produced by poxviruses: vaccinia, cowpox, off, molluscum contagiosum and milker's nodes.

More commonly, skin lesions occur secondarily to systemic spread, when they constitute a rash, as in the exanthemata of childhood. Rashes are more easily seen in human beings than in furred and feathered beasts, hence most of the descriptive data are derived from human infections. The individual lesions in generalized rashes are described as macules, papules, vesicles, or pustules. A lasting local dilation of subpapillary dermal blood vessels produces a macule, which becomes a papule if there is also edema and an infiltration of cells into the area. Primary involvement of the epidermis usually results in vesiculation, ulceration, and scabbing, but prior to ulceration a vesicle may be converted to a pustule if there is a copious cellul~ exudate. Secondary changes in the epidermis may lead to desquamation. More severe involvement of the dermal vessels may lead to hemorrhagic and petechial rashes, although coagulation defects and thromocytopenia may also be important in the genesis of such lesions. Information on the occurrence of rashes in human viral infections is set out in Table 4 . 

Genital infection with viruses occurs commonly with herpes simplex type 2 and sometimes with human cytomegalovirus and the human wart virus.

In females, vulvovaginitis with or without cervicitis, can be primary or recurrent. Herpes simplex type 2 infection has been closely correlated with subsequent development of cervical carcinoma but there is no proof that the association is a causal one. Other viruses, notably echovirus type 4, have also been reported to be associated with cases of cervicitis.

Virus is regularly shed in the urine during generalized infections by many paramyxoviruses, herpetoviruses, adenoviruses, togaviruses, arenaviruses, hepatitis viruses, rubella, and the human polyomavirus. As far as is known, however, viruria is not an indication of impairment of renal function. Only in cytomegalovirus infections is there clear evidence of kidney pathology. A temporary decrease in creatinine clearance has been observed in mumps.

Glomerulonephritis, which is an occasional feature of hepatitis B infection, is attributable to the accumulation of viral antigen-antibody complexes in glomeruli. Such immune complex disease is a frequent manifestation of chronic viral infections in animals and may be more common in man than we yet appreciate. A careful search for viruses, or immunoglobulin deposits, or complement depletion in human glomerulonephritis, may reveal that some 'idiopathic' cases are in fact due to persistent infection with known or unknown viruses.

Acute hemorrhagic cystitis characterized by hematuria, frequency, and dysuria has recently been associated with adenovirus types 2, 11, and 21 (Table 5) . 

Adenovirus type 8 causes epidemic keratoconjunctivitis in man, the only clinical disease caused by Newcastle disease virus in man is conjunctivitis, and herpes simplex virus is one of the most common infectious causes of blindness. When smallpox vaccination was practiced, accidental transfer to the eye, causing conjunctivitis, sometimes occurred (Table 5) . Such ocular infections are important to pharmacologists, for they present the possibility of local chemotherapy with drugs that might not be tolerated systemically, e.g. halogenated pyrimidine nucleosides in ocular herpes simplex.

When conjunctivitis occurs as part of a systemic illness, as in measles, the virus has reached the eye via the blood stream.

Respiratory viruses, and those that cause gastroenteritis, produce symptoms, usually after a short incubation period (Table 1) , referable to the respiratory or gastroin-testinal tract respectively. Many other viruses that may enter via these or other portals produce symptoms only after they have spread to other parts of the body.

Systemic disease usually follows the distribt/tion of virus via the bloodstream; the presence of virus in the bloodstream is known as viremia. Such a generalized infection may be inapparent, or it may produce systemic symptoms or symptoms associated with lesions in a particular organ, which differ characteristically with different viruses. The principal 'target' organs are the skin and the central nervous system; more rarely the liver, heart, and certain glands may be chiefly affected. Viremia occurs in most viral infections, even though it may not be readily detectable. Rhinovirus infections and infection of the skin with warts virus may be exceptions.

In the blood, viruses may occur free in the plasma or may be characteristically associated with particular types of leukocytes, with platelets, or with erythrocytes. Leukocyte-associated viremia is a feature of several types of infection, including measles and smallpox, for example. Many viruses multiply in macrophages; others, e.g. EB virus, multiply in lymphocytes. Occasionally virus is adsorbed to erythrocytes as in Rift Valley fever, Colorado tick fever, and lymphocytic choriomeningitis. Often virus circulates free in the plasma; all the togaviruses and the enteroviruses that cause viremia fall into this group. Finally, in some infections the viremia is mixed, i.e. the virus is partly in the plasma and partly cell-associated.

Whether virus circulates free in the plasma or is cell-associated affects its passage from the circulation to extravascular sites. Leukocytes can pass through the walls of small vessels by diapedesis, and infected leukocytes can thus initiate infection in various parts of the body. On the other hand, virus in the plasma may escape from circulation by being ingested by a cell in contact with the blood, either a macrophage or a capillary endothelial cell. Extravascular infection by such viruses may follow growth of the virus through the endothelial cells of the small blood vessels, or the virus may be transferred across the cell without growing in it.

Virus circulating in the blood is continually removed by cells of the reticuloendothelial system. Viremia can therefore be maintained only if there is a continued release of virus into the blood from cells in contact with it, or if the clearance system 'is grossly impaired. The circulating leukocytes could themselves constitute a source of replicating virus; indeed blood leukocytes maintained in culture (from which polymorphonuclear leukocytes are rapidly lost) support limited replication of many viruses. However, viremia is maintained primarily by organs with extensive sinusoids, like the liver, spleen and bone marrow, the endothelial cells of the blood vessels themselves, and the lymphoid tissues (via the thoracic duct). Cells of the voluntary muscles may be an important site of multiplication of some enteroviruses and togaviruses.

Our understanding of the pathogenesis of systemic infections associated with a rash, such as smallpox, measles, and rubella, is based on studies with mousepox, upon which Fig. 6 is based. In each such exanthem, there is an incubation period of 10-12 days before symptoms of illness appear. After multiplication of the virus at the site of implantation and in the regional lymph nodes, a primary viremia occurs within the first few days, resulting in seeding of organs such as the liver and spleen. A secondary viremia then follows with focal involvement of the skin and mucous membranes, the appearance of a rash, and onset of symptoms. In mousepox, a primary lesion develops at the site of inoculation. Generalized symptoms and fever are probably caused by antigen-antibody complexes which are found at the end of the incubation period. In diseases like measles and rubella the rash has an immunopathologic basis; in smallpox, chickenpox, herpes simplex, and herpes zostcr the relevant viruses are present in the skin vesicles and this may be an important mode of viral excretion. 

Disease of the central nervous system (CNS) is.an exceptional complication rather than the normal consequence of infection, even with the togaviruses and enteroviruses most commonly incriminated (Table 6 ). Some togaviruses, like Japanese encephalitis virus, involve the CNS but never produce a rash, whereas others, like dengue, do the reverse. Many of the enteroviruses occasionally produce meningitis, and polioviruses characteristically attack the anterior horn cells of the spinal cord in a small proportion of infected human beings. Several of the herpetoviruses affect nerve cells; herpes simplex virus is probably the most common cause of sporadic fatal encephalitis in man, while herpes zoster is due to the activation of chickenpox virus, latent in ceUs of the posterior ganglia. Encephalitis occurring after measles is thought to be an autoimmune disease, possibly associated with limited viral multiplication in the neurons. The rare disease called subacute sclerosing panencephalitis is a late manifestation of CNS infection with measles virus, and another rare disease called progressive multifocal leukoencephalopathy is caused by a papovavirus.

Hematogenous Spread. Viruses can spread from the blood to the brain cells by several routes. Growth through the endothelium of small cerebral vessels has been clearly demonstrated in several systems, and there is suggestive evidence that virions may sometimes be passively transferred across the vascular endothelium. The production of meningitis rather than encephalitis by enteroviruses, and the ease with which these agents are recovered from the cerebrospinal fluid, can be explained by postulating that the virus in the blood either grows or passes through the chorioid pluxus. Neural Spread. Spread from the periphery to the CNS is possible without generalization of viruses through the blood stream, for the peripheral nerves and the nerve fibers of the olfactory bulb offer potential direct pathways. Although earlier workers thought in terms of spread via 'conduits'--the axon, the lymphatics, and the tissue spaces between nerve fibers--the route of spread along peripheral nerves is usually by growth within endoneural cells, a fact demonstrated experimentally with herpetovirus infections by fluorescent antibody staining methods. However, this cannot be the only method of neural spread, for in experiments with rabies virus, no fluorescent endoneural cells could be found, the dorsal root ganglion cells being the first cells showing specific staining.

Apart from rabies and B virus (simian herpes) infections of man after monkey bites, no examples of neural spread have been established in natural human infections. However, transmission in the reverse direction, from the dorsal root ganglia down the corresponding peripheral nerves, appears to be the most likely mode of spread of virus in herpes zoster and recurrent herpes simplex.

Cytocidal infections of neuronal cells, whether due to poliovirus, a togavirus, or a herptetovirus, are characterized by the three hallmarks of encephalitis: cell necrosis, phagocytosis by glial cells (neuronophagia), and perivascular infiltration of inflammatory cells, which is an expression of cell-mediated immunity. The cause of symptoms in other CNS infections is more obscure. Rabies virus is noncytocidal in cultured cells; in infected animals it evokes none of the inflammatory reactions of cell necrosis found in the encephalitides, yet it is highly lethal for most species of animal. With some other viruses, infection of neurons causes no symptoms, for example, the extensive CNS infection of mice congenitally infected with lymphocytic choriomeningitis virus, readily demonstrable by fluorescent antibody staining, has no deleterious effect. Still other changes are produced by some of the viruses that cause slowly progressive diseases of the CNS (see below). In scrapie of sheep, for example, there is slow neuronal degenration and vacuolization; in "visna (another chronic disease of sheep), changes in cell membranes lead to demyelinization.

Post-infection encephalitis is most commonly seen after smcllpox vaccination and measles. The pathological picture is predominantly demyelinization without neuronal degeneration---changes unlike those produced by the direct action of viruses on the CNS. Allied with the failure to recover virus from the brain, this has led to the view that post-infection encephalitis is probably an autoimmune disease.

Oncovirus infections of chickens and rodents persist in these species by the congenital transfer of the viral genome, which is integrated into the chromosomes of the host's cells as a DNA copy of the viral RNA. In addition, viremia in the mother may be followed by congenital transfer of virions in these as well as in a variety of other infections (Table 7) . Congenital infection may occur at any stage from the development of the ovum up to birth. With noncytocidal viruses, like lymphocytic choriomeningitis in mice, every cell in the embryo's body may be infected. In severe acute viral infections (e.g. smallpox), congenital infection may cause fetal death and abortion. More important are the viruses which do not kill the embryo but produce congenital malformations due to interference with the normal development of particular organs or tissues.

By far the most detailed observations on congenital defects are those made on human infants whose mothers were infected with rubella virus early in pregnancy. A variety of abormalities has been recognized, of which the most severe are deafness, blindness, and congenital heart and brain defects. These t.efects may only be recognized after the birth of an apparently healthy baby, or they may be associated with severe neonatal disease--hepatosplenomegaly, purpura, and jaundice---to comprise the 'rubella syndrome'.

Little is known of the pathogenesis of congenital abnormalities in rubella. Damage occurs mainly in fetuses infected during the first trimester. Immunological tolerance does not develop; children who have contracted rubella in utero display high titers of neutralizing antibodies throughout their lives. Usually, in the infected human fetus, as in most types of cultured cells, rubella virus is relatively noncytocidal; few inflammatory or necrotic changes are found. The retarded growth in rubella-infected infants may be due to slowing of cell division leading to the reduced numbers of cells observed in many of their organs. Apart from rare activation of latent infections, disease due to the cytomegaloviruses usually results from infection acquired congenitally from mothers suffering an inapparent infection during pregnancy. Virus-infected cells are present in the chorionic villi. The important clinical features in neonates include hepatosplenomegaly, thrombocytopenic purpura, hepatitis and jaundice, microcephaly, and mental retardation.

In certain viral infections it is clear that the immune response itself is a major factor in causing pathological changes and, hence, disease. A good example is lymphocytic choriomeningitis (LCM) virus, which is lethal for untreated adult mice but nonpathogenic in the absence of an immune response. Thus, mice infected as adults can be protected by X-irradiation, neonatal thymectomy, antilymphocyte or anti-0 serum, or other immunosuppressive treatments, despite the fact that viral growth is similar in normal and immunosuppressed animals. In normal adult mice the cell-mediated immune response to LCM infection, though beneficial in eliminating virus from organs such as lung, liver, and spleen, is also responsible for lethal inflammatory changes in the brain. Adoptive transfer of immune T cells has been shown to induce lesions in the chorioid plexus and meninges in adult mice infected with LCM virus and immunosuppressed with cyclophosphamide treatment. Recipients of immune T cells do not produce significant amounts of antibody before dying of classic LCM disease, thus suggesting that cell-mediated immunity rather than humeral factors is responsible. Further, T cells cytotoxic for LCM-infected target cells in vitro can be isolated from the cerebrospinal fluid of moribund mice, and levels of such T cells in the spleen are maximal at the time of onset of the lethal disease.

In other situations, the humeral immune responses to LCM virus can be pathogenic. Mice infected neonatally or in utero show immunological tolerance (see below) with lifelong and widespread infection of tissues, but their tolerance is incomplete. Throughout life, small amounts of antibody are produced which react with virus in the blood to form 'immune complexes', and these are precipitated out in kidney glomeruli, eventually causing glomerulonephritis. Antibody carl be eluted from glomeruli, and treatments that increase or decrease antibody formation will increase or decrease the severity of glomerulonephritis. Glomerulonephritis (and arteritis) due to such immune complexes is important in several other persistent infections.

When certain classes of antibodies react with antigens on the surface of infected cells, fixation of complement can lead to cell lysis. This has been shown to occur in vitro, not only with LCM but with a number of other noncytopathic and cytopathic viral infections. There is no clear evidence about the part played by such reactions in the infected host, but activation of complement would result in the release of mediators of inflammation and thus cause pathological changes.

The immune response has been invoked as a major cause of pathological changes in many other viral infections, though the evidence is generally less complete than with the LCM model system. For example, there are good reasons for supposing that the T cell-mediated response to measles infection is responsible not only for recovery from the disease but also for the rash which characterizes the disease itself. On infection with measles virus, patients with a defective T cell response due to various lymphoreticular tumors with or without associated immunosuppressive chemotherapy, or thymic aplasia, may show progressive growth of virus in the lungs leading to a fatal 'giant cell pneumonia', but no rash. Presumably the measles rash in normal children results from T cell-mediated cytolysis of virus-infected cells in the skin or capillary endothelium, and heralds recovery because these cells are destroyed immunologically before they have had time to yield large numbers of new virions.

Killed measles virus vaccines, now no longer used, were found to elicit the formation of circulating antibodies rather than cell-mediated immunity, and on subsequent infection with live virus there were unusual lesions in the skin and lungs, presumably immunopathological in nature. There was a similar experience with an experimental inactivated respiratory syncytial viral vaccine. It is likely that immunopathological mechanisms contribute to other viral diseases, such as dengue hemorrhagic fever, viral diseases of the central nervous system, and respiratory syncytial viral bronchiolitis in infants inheriting maternal antibody.

The balance between the humoral and the cell-mediated immune responses to a viral infection (or between the numbers of immune B and T cells respectively) probably plays a key role in both recovery and pathogenesis. Recovery often depends on one, rather than the other, arm of the immune response. Elucidation of the types of experimental manipulation favouring either type of response may introduce a new era of 'immunological engineering' that will make vaccines more effective, and at the same time increase our understanding of viral immunopathology.

It has long been known that when tuberculin-positive individuals suffer from measles, they temporarily become tuberculin-negative, and studies of Eskimos in Greenland have shown that measles exacerbates pre-existing tuberculosis. Cultured human T lymphocytes will support the growth of measles virus, and such infected cells fail to respond to tuberculin, like lymphocytes taken from individuals rendered temporarily tuberculin-negative by measles.

Direct tests for immune function have shown that several other viral infections influence the immune responses. Immunodepression is seen, for instance, in mice infected with leukemia viruses, cytomegalovirus, lymphocytic choriomeningitis virus and in chickens with Marek's disease or avian leukosis. The reduced response is to unrelated antigens, and is thus distinct from the immunologically specific effect seen in tolerance. Most reports deal with depressed antibody responses. Cell-mediated immunity is more difficult to measure, but delayed skin graft rejection has been described in mice infected with leukemia and lactic dehydrogenase viruses. Human patients with leukemia, iymphomas, or Hodgkin's disease, diseases which may be caused by viruses, usually exhibit immunodepression even in the absence of treatment with cytotoxic drugs, but one must be cautious about too facile an interpretation of this observation.

The mechanism of immunodepression is not understood, but probably results from the multiplication of virus in lymphocytes and/or macrophages. Many viruses are capable of replication in macrophages, and several viruses have now been shown to grow in T cells which have been stimulated by mitogens (concanavalin A or phytohemagglutinin) to divide in vitro, while a few others have been grown in cultured B cells. The immune responses are depressed, but not abolished, and individual lymphocytes infected with murine leukemia virus, for instance, can at the same time produce antibody to sheep red cells.

Immunodepression by infectious agents is not restricted to viruses; it has been demonstrated in several nonviral infections including leprosy, malaria, and leishmaniasis.

Many physiological responses other than the immune response affect the resistance of animals to viral infections. Our knowledge of these is sketchy; here we shall do little more than mention the existence of some factors and discuss briefly those for which there is more precise information.

Polymorphs play no part in protection against viral infections, but macrophages, particularly the 'fixed' macrophages of the reticuloendothelial system, are very important in pathogenesis. Several organs (liver, spleen, bone marrow) contain blood sinuses which are partially or completely lined by macrophages and similar phagocytic cells which monitor the lymph, the pleural and peritoneal cavities, the respiratory tract, and the connective tissue throughout the body. Macrophages play an important role in clearing viruses from the bloodstream and preventing the infection of susceptible cells in target organs.

However some viruses, rather than being digested by the macrophages that ingest them, actually multiply preferentially in these cells. Indeed, circulating macrophages (the monocytes of the blood) may transport replicating viruses around the body as a cell-associated viremia, so helping to disseminate the infection. On the other hand, infected macrophages produce substantial amounts of interferon and thus protect susceptible cells from infection. They also appear to be important in the process of recovery from infection which is triggered by immune T cells, as described below.

Interferon produced during the course of a viral infection protects some cells from infection, especially locally but perhaps also in distant target organs (Fig. 7) . However, it has proved difficult to devise decisive experiments fo evaluate the importance of these effects in promoting recovery, since there are no known naturally occurring diseases of man or animals in which there is a specific defect in interferon production. However, there is much circumstantial evidence that interferon is important in recovery from viral infection. Decreased interferon production caused by altered temperature, chemical inhibitors, or different viral strains has been correlated with impaired recovery, but the situation is often complex. The virulence of some viruses is associated with a weak interferon response, but in other instances there is no correlation. The responsiveness of infected cells to interferon action may be important. For example, mice of the C3HRV strain are much more resistant than C3H mice to flavivirus infections. Although both produce equal amounts of interferon, the cells of the resistant mice are more susceptible to the action of interferon, i.e. a genetic difference in interferon sensitivity rather than interferon production appears to determine the severity of infection. Several other 'nonspecific' factors involved in resistance may operate at least in part by their effects on interferon production; this appears to be the case with body temperature, with some types of stress, and with the effects of some hormones. Despite the wealth of evidence (a) that interferon is produced as a by-product of most or all viral infections, and (b) that passively administered interferon can protect against certain viruses under limited experimental circumstances, there are some clinical observations which cast doubt on the primacy of the role of interferon in recovery from natural infections and at the same time temper optimism in relation to its possible therapeutic use. Neither natural infections with viruses nor immunization with live attenuated vaccines confers substantial protection against simultaneous or subsequent heterologous viral infections elsewhere in the body. Indeed, certain attenuated viruses can be combined to produce potent multivalent vaccines. Perhaps, under natural circumstances, interferon expedites recovery because transient high concentrations occur in the immediate vicinity of infected cells. It may be impossible, in terms of antiviral therapy, to produce enough interferon in the right place at the right time.

BODY TEMPERATURE Environmental temperature, and the level of endogenous temperature achieved during the febrile response, affect the multiplication of some viruses. Fever usually develops at the end of the incubation period, when the distribution of virus throughout the body has been completed. It may be an important protective mechanism in promoting recovery by limiting further viral multiplication.

Elevated body temperature promotes viral multiplication in the production of recurrent herpes simplex ('fever blisters') in man. Artifically induced fever precipitates an attack of herpes simplex in about 50 per cent of cases. Moreover, fever blisters are a frequent complication of some febrile diseases (malaria, influenza, steptococcal and pneumococcal infections), but are very rarely found in others (tuberculosis, smallpox, typhoid fever).

Several other nonspecific factors play a role in both susceptibility to viral infection and recovery. There is not space to do more than mention them: hormones (especially the corticosteroids), nutritional deficiencies, stress, trauma, concurrent infection and age of the host animal. There are also important genetic factors acting at the species level, usually associated with the presence or absence of specific cellular receptors; or within species, via the/~ (immune response) genes.

In the past, the significance of the immune response of the infected host has been largely assessed in terms of acquired immunity to reinfection, in which antibody plays the key role. Viral vaccines are designed to generate such antibodies. Less attention has been paid to the role of the immune response in recovery from viral infections. The coincidence in time between recovery and the appearance of circulating antibodies, and the protection conferred by 'passi~,e immunization' with antiserum given during the incubation period of measles, originally led immunologists to believe that the humoral response was important in promoting recovery. However, the natural experiment of human dysgammaglobulinemia has cast doubt on the importance of antibodies in recovery from viral infection. Though subjects with such B cell deficiencies suffer from recurrent and intractable bacterial infections, which can be partially controlled by the administration of y-globulin, they recover from viral infections in a normal fashion in spite of very low levels of y-globulin and often no detectable production of specific antibodies. By contrast children with congenital or acquired T cell deficiencies are known to be extremely vulnerable to viral infections and often succumb to otherwise, trivial diseases such as measles, varicella, or cytomegalovirus.

The respective roles of antibodies, T cells, macrophages, and interferon in recovery from viral infections have been the focus of much recent research in animals and cell culture.

Experiments in which the immunological responsiveness of animals is totalty suppressed by irradiation or cytotoxic drugs, then selectively restored by administration of antibody, reveal that viruses which produce systemic diseases with a plasma viremia can be controlled by antibody. For example, if adult mice that have been inoculated with coxsackievirus or yellow fever virus are treated with cyclophosphamide, which greatly reduces antibody production, they die from infections that cause no symptoms in untreated animals. Passive immunization with specific antibody as late as 2-4 days after infection prevents the death of such immunosuppressed mice. Neonatal thymectomy, which suppresses T cell-mediated immunity, does not increase the susceptibility of mice to enterovirus infections, suggesting that this immune response plays only a minor role in recovery from these infections. Likewise, children with severe hypogammaglobulinemia, but intact cell-mediated immunity, are more liable to develop paralytic poliomyelitis after exposure to vaccine strains than are normal children.

Restoration experiments with secretory IgA in respiratory virus infections are difficult to carry out. However, since antilymphocyte serum has no detectable effect on the pathogenicity for mice of either influenza or parainfluenza viruses, antibodies available on the epithelial surfaces (i.e. secretory antibody) probably play a role in recovery.

Although attention is usually concentrated on the effects of neutralizing antibodies in relation to recovery, other kinds of antibody may also be important. For example, antibody directed against any viral antigen present in infected tissues could, by forming immune complexes, induce the inflammatory infiltrates that lead to an antiviral effect. Conceivably antibody, cell-mediated immunity, and interferon each play a part in recovery from all viral infections, although their relative importance may vary considerably in different situations.

There is ample evidence that viruses elicit 'cell-mediated' immunity (CMI). This is demonstrable by delayed hypersensitivity following intradermal injection of viral antigens into a previously infected animal, including man; the capacity to respond in this way is transferable by lymphocytes but not by serum. T cell-mediated immunity is largely abrogated by neonatal thymectomy and treatment with antilymphocyte (or better still, in mice, anti-0) serum. Such treatments greatly aggravate infections of mice due to herpetoviruses and poxviruses, but have little effect on enterovirus or togavirus infections (Table 8) .

Restoration experiments confirm the importance of T cell-mediated immunity in recovery from systemic infections in which viremia is cell-associated. For example, mice infected with sublethal doses of ectromelia virus (a poxvirus) died if they were treated with antilymphocyte or anti-0 serum, apparently as a result of the uncontrolled growth of virus in the liver. Antilymphocyte serum suppresses the CMI response, but not the antibody or interferon responses to ectromelia virus. Transfer of immune splenic lymphocytes to mice infected one day earlier with ectromelia virus caused striking inhibition of viral growth and a fall in viral titer in target organs, the liver and spleen. This protective effect was greatly reduced when transfused cells were first treated with anti-0 serum plus complement, which kills T, but not B, lymphocytes. The recipients of the immune cells did not develop detectable antibody. When mouse hyperimmune anti-ectromelia serum was transfused, antibody reached a high titer in recipients (far higher than that achieved in a normal primary response), and there was some inhibition of viral growth, but no fall in viral titer such as is produced by transfer of immune cells. Passively administered interferon had no effect. Prior irradiation of recipients markedly impaired the antiviral effects of immune cells or hyperimmune serum, probably by inactivating radiosensitive precursors of blood monocytes (macrophages), since in unirradiated recipients monocyte invasion of virus-infected foci in the liver coincided with elimination of the virus. This train of experimental evidence shows that 'sensitized' (i.e. immune) T cells are the primary agents of the antiviral effect and the macrophages collaborate with them in the recovery process. Several mechanisms have been postulated to account for the antiviral effects of sensitized T cells. By liberating lymphokines on exposure to antigens in tissues, they induce the migration and activation of macrophages which, perhaps with the help of opsonizing antibody, phagocytose and digest virions and infected cell debris. Further, sensitized T cells that encounter intact infected cells which bear virus-induced antigens on their surface kill such cells before virus is liberated; such T cell-mediated lysis has been demonstrated in vitro with several viruses. Finally, sensitized lymphocytes may liberate interferon on exposure to antigen, and in some infections this could have a significant local antiviral effect.

Thus, T cell-mediated immunity plays a central role in recovery from at least some viral infections, especially those generalized infections in which infected cells display virus-induced antigens on their surfaces.

In the acute febrile infections that have been described so far, the causative virus enters the body, multiplies in one or more tissues, and spreads either locally or through the bloodstream. When viral multiplication has reached a critical level, after an incubation period of 2 days to 2 or 3 weeks, symptoms of disease appear, associated with localised or widespread tissue damage. Nonspecific and specific host defenses are mobilized during the incubation period and, unless the disease is fatal, the host has usually eliminated the infecting agent within 2 or 3 weeks of the onset of symptoms. Virus can ordinarily be isolated from the blood or secretions only in the short period just before and just after the appearance of symptoms. Some viruses (e.g. measles and smallpox in man) almost always cause acute disease; many others produce acute infections in which the pathogenic mechanisms are similar but often there is no clinical disease, i.e. the infection is subclinical (see Table 9 ).

Quite distinct from the acute infections, however, are those in which virus persists for months or years, i.e. persistent viral infections. Persistent infections are associated with a great variety of pathogenic mechanisms and clinical manifestations, and it is difficult to classify them satisfactorily. Because of this we shall have to draw rather heavily on experimental and natural infections inanimals, as well as on observations made in human diseases. For convenience, we shall subdivide the persistent infections into three categories, recognising that there is some overlap. 1. Persistent infections with intermittent acute episodes of disease between which virus is usually not demonstrable: latent infections. The important examples of these are herpes simplex and varicella-zoster, in each of which the causative virus persists in a latent state in association with sensory nerve ganglia, and may periodically, or after a long interval, be activated and produce symptoms (recurrent cold sores or shingles, respectively; see Fig. 8 ). 2. Persistent infections in which virus is always demonstrable and often shed, but disease is either absent, or is associated with immunopathological disturbances: chronic infections. Several other herpesvirus infections fall into this category, e.g. cytomegalovirus and E.B. virus; as does the virus of hepatitis B and, to some extent, rubella in infants infected in utero.

3. Persistent infections with a long incubation period followed by slowly progressive disease that is usually lethal: slow infections. This class includes three important but rare human diseases: kuru and Creutzfeld-Jacob disease, subacute sclerosing panencephalitis (measles virus) and progressive multifocal leukoencephalopathy (human papovavirus).

The key distinctions between these three groups of persistent infections are illustrated diagrammatically in Fig. 9 . In slow infections, the concentration of virus in the body builds up gradually over a prolonged period until disease finally becomes manifest. Chronic infections, on the other hand, can be regarded as acute infections (clinical or subclinical) following which the host fails to reject the virus; sometimes disease supervenes late in life as a result of an immunopathological or neoplastic complication. The distinction between chronic infections and latent infections, e.g. herpetoviruses between recrudescences of endogenous disease, may be a fundamental one concerned with the state of the virus between attacks, or it may be merely a matter of the ease of demonstration of infectious virus.

Acute lnfeutlm (~--!!l-~x) 

Several mechanisms appear to be involved in determining whether a viral infection will follow an acute course with complete recovery and immunity to re-infection, or persist. Some factors involve the virus, others the host defense mechanisms.

The unknown agents that cause kuru and Creutzfeld-Jacob disease seem to be completely non-immunogenic, they fail to induce interferon, and they are not demonstrably susceptible to interferon action. There appears to be no mechanism whereby the host can control the multiplication and pathological effects of these agents.

RNA tumor viruses persist as DNA copies of their genomes integrated into cellular genomes. Until activated, the viral genome is only partially expressed, if at all, and it can be regarded as part of the cellular genetic material. When activated, the RNA tumor viruses multiply in lymphoid tissue and induce the production of non-neutralizing, rather than neutralizing, antibodies.

Among DNA viruses, the papovavirus of progressive multifocal leukoencephalopathy may well persist as an integrated genome until it is activated. Among the herpetoviruses, those associated with or thought to be associated with malignancies probably persist as integrated, perhaps defective, genomes. The state in which herpes simplex, varicella-zoster, cytomegalovirus, and EB virus persist intracellularly during prolonged latent infections is unknown, but integration (of complete genomes) is a likely possibility.

The strains of virus responsible for several of the persistent infections of animals or cultured cells with 'orthodox' viruses have turned out to be ts mutants, although most ts mutants do not cause persistent infections. The significance of this discovery has yet to be determined.

Herpes simplex virus and varicella virus avoid immune elimination by remaining within cells of the nervous system, in an occult form in the ganglion cells during the intervals between disease episodes, and within the Schwann cells of the nerve sheaths prior to acute recurrent episodes of disease. Likewise, other herpetoviruses such as human cytomegalovirus and EB virus appear to bypass immune elimination, but in this instance they persist in lymphocytes. Other viruses grow in cells in epithelial surfaces, e.g. kidney tubules, salivary gland, or mammary gland, and are persistently shed in the appropriate secretions and excretions. Most such viruses are not acutely cytopathogenic and, perhaps because they are released on the lumenal borders of cells, they do not provoke an immunological inflammatory reaction, hence the cells are not destroyed by T lymphocytes or macrophages. Secretory IgA, which does have access to the infected cells, does not cause complement activation and therefore fails to induce complement-mediated cytolysis or an inflammatory response.

In many chronic infections the virus appears to grow mainly in lymphoid tissue, especially in macrophages. This may have two effects relevant to persistence: (a) modification of the antibody response, and (b) impairment of the phagocytic and cytotoxic potential of the reticuloendothelial system.

Viruses that cause persistent plasma-associated viremia usually multiply in lymphoid tissue and macrophages (see above) and they characteristically induce production of non-neutralizing antibodies. These antibodies combine with viral antigens and virions in the serum to form 'immune complexes' which may (a) produce 'immune complex disease' and (b) block immune cytolysis of virus-infected target cells by T lymphocytes or complement-fixing antibodies.

Many persistent infections are associated with a very weak antibody response, especially in congenitally infected animals. Immunological tolerance is rarely complete, but there is a severe degree of specific hyporeactivity in conditions like congenital lymphocytic choriomeningitis and retrovirus infections. Tolerance to a viral antigen may be genetically determined, and the immune response to several specific antigens has been shown to be under genetic control.

Another kind of 'tolerance', about which very little information is available, is what might be called 'interferon-tolerance'. Little or no interferon is produced in mice congenitally infected with lymphocytic choriomeningltis, lactic dehydrogenase, or routine leukemia viruses, but in each case the causative virus is sensitive to interferon. Interferon 'tolerance' appears to be specific to the virus involved, possibly involving a recognition mechanism at the messenger RNA level. Experiments with varicella cast doubt on the suggestion that low interferon production and low sensitivity are invariably characteristics of viruses that produce persistent infections, but this would hardly be expected in such a diverse group.

Persistent infections could be caused by partial suppression of the host's CMI response, as a result of any one or combination of several factors: immunodepression by the causative virus, immunological tolerance, the presence of 'blocking' antibodies or virus-antibody complexes, failure of immune lymphocytes to reach target cells, or inadequate expression of viral antigens on the surface of the target cell. These factors are probably important in persistent infections such as visna, subacute sclerosing panencephalitis and progressive multifocal leukoencephalopathy, and in those caused by herpetoviruses. Finally, we may again note that many persistent viruses multiply extensively in macrophages and lymphocytes, and thus affect several parameters of the immune response. Indeed, depressed CMI may diminish the rate of destruction of infected cells and thereby prolong the release of viral antigens. The resulting protracted immunogenic stimulus would explain the very high antibody levels found in subacute sclerosing panencephalitis and Aleutian disease of mink, for example, which may produce a cascade effect by blocking the already inadequate T cell defenses.

The incubation period of an infectious disease is the period that elapses between infection and the first manifestation of symptoms. Consideration of the mode of spread of viruses within the infected animal, set out earlier in this article, allows us to make some generalizations about the incubation period in natural infections (Table  10 ). It will tend to be short in diseases in which the symptoms are entirely due to viral multiplication at the portal of entry. Thus, respiratory viruses produce symptoms by virtue of their multiplication in the upper and/or lower respiratory tract and hence have short incubation periods (1-3 days). On the other hand, the incubation period will be relatively long (10-20 days) in generalized infections, like the common childhood exanthemata, measles, chickenpox, and rubella, where the virus spreads in stepwise fashion through the body before reaching the target organ in which symptoms are produced.

Other factors also influence the length of the incubation period. The generalized *Until first appearance of prodromal symptoms. Diagnostic signs, e.g. rash or paralysis may not appear until 2-4 days later.

tMost viral diseases are highly transmissible for a few days before symptoms appear. Long = > 10 days; short = < 4 days.

*High ffi > 90 per cent; low = < 10 per cent.

infections produced by togaviruses may have an unexpectedly short incubation period attributable to the direct intravenous injection by an insect of a rapidly multiplying virus. Conversely, the long incubation periods of some localized infections like warts and molluscum contagiosum are presumably due to slow multiplication of the viruses concerned. An extreme, but poorly understood, case is that of the so-called slow virus infections and the viral leukemias, where the virus-cell interaction is initially noncytocidal and symptoms may not appear for many months or even years after infection.

this one embraces a field that is basic to planning antiviral chemotherapy but is not about chemotherapy. It is impossible to provide adequate references; instead the interested reader is referred to Mires (1976) for an excellent extended account of the subject and to Fenner

The Biology of Animal Viruses

The Pathogenesis of Infectious D/sease

19/6) Viral Infections of Humans